Home
Conditions
Hepatitis, Chronic

Clinical trial condition

Hepatitis, Chronic

Explore clinical trials studying Hepatitis, Chronic. Study availability and eligibility vary by location and protocol.

1,281 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis, Chronic trial results

Completed

A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

NCT02569372

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Severance Hospital Seoul, South Korea

View Trial Details

Completed

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

NCT02850289

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

View all 46 locations

View Trial Details

Completed

Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults

NCT02476617

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Not specified

View Trial Details

Completed

A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response

NCT01033448

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Haemek Hospital; Gastroenterology Afula, Israel

Clalit City Ashdod MC; Liver Clinic Ashdod, Israel

Batyamon; Liver Unit Bat Yam, Israel

Soroka Medical Center; Gastroenterology Beersheba, Israel

View all 20 locations

View Trial Details

Completed

A Study of Predictors of the Effectiveness of Pegylated Interferon in a Cohort of Participants With Hepatitis C

NCT01659567

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Hepatology Clinic Hepa Tbilisi, Georgia

Infectious Diseases, AIDS and Clinical Immunology Research Center Tbilisi, Georgia

Ltd Mrcheveli Tbilisi, Georgia

View Trial Details

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

NCT02446717

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +18 more
Locations: Not specified

View Trial Details

Completed

Phase 2, Multiple Ascending Dose Proof of Concept Study

NCT02710604

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Bangkok, Thailand

View Trial Details

Completed

Interferon/Ribavirin-Free Sofosbuvir Based Treatment (AURIC)

NCT02628717

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +17 more
Locations: Medical University of Vienna Vienna, Austria

View Trial Details

Completed

A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)

NCT02265237

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study

NCT02201407

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Clinic for Gastroenterology and Hepatology Belgrade, Serbia

Clinical Center of Serbia; Institute For Infectious Diseases Belgrade, Serbia

Clinical Center Zemun Belgrade, Serbia

Clinic for Infectious Diseases CC Kragujevac Kragujevac, Serbia

View Trial Details

Hepatitis, Chronic

Hepatitis, Chronic trial results

Related conditions